Are generic manufacturer patents driving up drug prices?
A study from the University of Melbourne shows that Australia’s most expensive drugs are attached to patents not held by the innovator company
The paper, entitled "Patents Associated with High-Cost
Drugs in Australia", examined 15 of the costliest drugs in
Australia over the past 20 years and the patents associated
with them, and found that each had an average of 49 associated
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.